In summary, EPA and DHA when provided alone or in a mixture, reduce survival of triple negative, ER+, luminal B, and HER2+ BC cells in vitro, although when compared at the same dose, DHA appears to be more efficacious. Here, ERBB2 is linked to breast cancer.